Creative Biogene Launches A Large Panel of Genome Editing Services to Accelerate Bioprocess of Drug Development
Creative Biogene announced the release of its large panel of genome editing services to promote the bioprocess of drug development.
New York, USA – February 14, 2022 /MarketersMEDIA/ —
As the leading global biotechnology service and solutions provider for scientific research, Creative Biogene is always dedicated to accelerating the research progress in the field of pharmaceutical, biomedical and drug development etc. With the support of the expert team and innovative platform, Creative Biogene is gradually recognized by worldwide customers as a biotech institution specializing in fundamental life sciences research. Recently, Creative Biogene announced the release of its large panel of genome editing services to promote the bioprocess of drug development.
At present, a number of technologies have been applied to the transformation and improvement of industrial microbial strains, showing good application prospects in the process of strain breeding. In addition, microbial genome editing has also been widely used in pharmaceutical and environmental fields. Creative Biogene provides the best services in the field of microbial genome editing to help add new functionality or optimize existing biological processes. With many talented scientists and technicians, Creative Biogene has built an excellent and mature platform to modify a range of different microorganisms. By designing and optimizing the genetic code for microbial regulatory processes, Creative Biogene can increase yields of key compounds and also precisely edit a broad range of microorganisms.
The microbial gene-editing services provided by Creative Biogene cover a wide range of microbial species. With seamless genome editing, Creative Biogene can precisely edit each base pair quickly and efficiently. At this stage, Creative Biogene provides two different microbial genome editing service platforms, including traditional recombinant systems and CRISPR/Cas 9 systems.
With years of experience in the field of CRISPR-based genome editing, Creative Biogene can provide the highest quality services for microbial genome editing. Creative Biogene has developed proven systems for a wide range of microorganisms, including all Gram-negative bacteria (Escherichia coli, Enterobacter, Salmonella, Pseudomonas and other Gram-negative bacteria), Bacillus subtilis, Pichia and Saccharomyces cerevisiae etc.
Creative Biogene can provide optimal recombination-based microbial genome editing services for a wide range of microbial species. With the assistance of professional technicians, microbial genome editing projects can be completed at the most competitive price. Creative Biogene provides microbial genome mutation, insertion, gene knockout and metabolic pathway engineering services for a broad range of microorganisms through a proven recombinant platform. The microbial targets include, but are not limited to, Escherichia coli, Enterobacter, Salmonella, Pseudomonas, and other Gram-negative bacteria.
“With years of experience in the field of gene editing, Creative Biogene can provide the highest quality services for microbial genome editing.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “We are confident in carrying out customized solutions to satisfy diverse requirements in order to promote your research process.”
About Creative Biogene
Creative Biogene, the top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.
Contact Info:
Name: Marcia Brady
Email: Send Email
Organization: Creative Biogene
Address: Shirley, NY 11967, USA
Phone: 1 631 386 8241
Website: https://www.creative-biogene.com/
Source: MarketersMEDIA
Release ID: 89064064
Copyright © 1999-2013 SproutNews.com
